Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Tumor self-seeding by circulating tumor cells in nude mouse models of human osteosarcoma and a preliminary study of its mechanisms.

Zhang Y, Ma Q, Liu T, Ke S, Jiang K, Wen Y, Ma B, Zhou Y, Fan Q, Qiu X.

J Cancer Res Clin Oncol. 2014 Feb;140(2):329-40. doi: 10.1007/s00432-013-1561-7. Epub 2013 Dec 27.

PMID:
24370684
2.

Dynamic analysis of lung metastasis by mouse osteosarcoma LM8: VEGF is a candidate for anti-metastasis therapy.

Tanaka T, Yui Y, Naka N, Wakamatsu T, Yoshioka K, Araki N, Yoshikawa H, Itoh K.

Clin Exp Metastasis. 2013 Apr;30(4):369-79. doi: 10.1007/s10585-012-9543-8. Epub 2012 Oct 18.

3.

CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.

Wang SW, Liu SC, Sun HL, Huang TY, Chan CH, Yang CY, Yeh HI, Huang YL, Chou WY, Lin YM, Tang CH.

Carcinogenesis. 2015 Jan;36(1):104-14. doi: 10.1093/carcin/bgu218. Epub 2014 Oct 20.

4.

STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma.

Tu B, Du L, Fan QM, Tang Z, Tang TT.

Cancer Lett. 2012 Dec 1;325(1):80-8. doi: 10.1016/j.canlet.2012.06.006. Epub 2012 Jun 26.

PMID:
22743617
5.

Interleukin-6 induces vascular endothelial growth factor expression and promotes angiogenesis through apoptosis signal-regulating kinase 1 in human osteosarcoma.

Tzeng HE, Tsai CH, Chang ZL, Su CM, Wang SW, Hwang WL, Tang CH.

Biochem Pharmacol. 2013 Feb 15;85(4):531-40. doi: 10.1016/j.bcp.2012.11.021. Epub 2012 Dec 5.

PMID:
23219526
6.

Human mesenchymal stem cells promote growth of osteosarcoma: involvement of interleukin-6 in the interaction between human mesenchymal stem cells and Saos-2.

Bian ZY, Fan QM, Li G, Xu WT, Tang TT.

Cancer Sci. 2010 Dec;101(12):2554-60. doi: 10.1111/j.1349-7006.2010.01731.x. Epub 2010 Sep 28.

7.

CXCR4-mediated osteosarcoma growth and pulmonary metastasis is promoted by mesenchymal stem cells through VEGF.

Zhang P, Dong L, Yan K, Long H, Yang TT, Dong MQ, Zhou Y, Fan QY, Ma BA.

Oncol Rep. 2013 Oct;30(4):1753-61. doi: 10.3892/or.2013.2619. Epub 2013 Jul 17.

PMID:
23863999
8.

The overexpression of BAMBI and its involvement in the growth and invasion of human osteosarcoma cells.

Zhou L, Park J, Jang KY, Park HS, Wagle S, Yang KH, Lee KB, Park BH, Kim JR.

Oncol Rep. 2013 Sep;30(3):1315-22. doi: 10.3892/or.2013.2569. Epub 2013 Jun 26.

PMID:
23807684
9.

Interleukin-6 suppression reduces tumour self-seeding by circulating tumour cells in a human osteosarcoma nude mouse model.

Zhang Y, Ma Q, Liu T, Guan G, Zhang K, Chen J, Jia N, Yan S, Chen G, Liu S, Jiang K, Lu Y, Wen Y, Zhao H, Zhou Y, Fan Q, Qiu X.

Oncotarget. 2016 Jan 5;7(1):446-58. doi: 10.18632/oncotarget.6371.

10.

[Therapeutic effects of small interfering RNA targeting MDM2 on human osteosarcoma cells].

Lü JY, Gao ZL, Wang JC, Wu DK, Zhao DX, Zhang DD, Zhao YY.

Zhonghua Zhong Liu Za Zhi. 2008 Jul;30(7):502-5. Chinese.

PMID:
19062715
11.

Circulating levels of transforming growth factor-βeta (TGF-β) and chemokine (C-X-C motif) ligand-1 (CXCL1) as predictors of distant seeding of circulating tumor cells in patients with metastatic breast cancer.

Divella R, Daniele A, Savino E, Palma F, Bellizzi A, Giotta F, Simone G, Lioce M, Quaranta M, Paradiso A, Mazzocca A.

Anticancer Res. 2013 Apr;33(4):1491-7.

PMID:
23564790
12.

[Morphological changes in osteosarcoma xenografts in nude mice after inhibiting angiogenesis by Ad-VEGF-siRNA].

Wang JQ, Gao YS, Mei J, Xue HM, Wang SQ, Cai XS.

Ai Zheng. 2009 Jun;28(6):581-6. Chinese.

PMID:
19635194
13.

Antitumour effects of Yangzheng Xiaoji in human osteosarcoma: the pivotal role of focal adhesion kinase signalling.

Jiang WG, Ye L, Ji K, Ruge F, Wu Y, Gao Y, Ji J, Mason MD.

Oncol Rep. 2013 Sep;30(3):1405-13. doi: 10.3892/or.2013.2586. Epub 2013 Jul 3.

PMID:
23828123
15.

Advantages of bioluminescence imaging to follow siRNA or chemotherapeutic treatments in osteosarcoma preclinical models.

Rousseau J, Escriou V, Perrot P, Picarda G, Charrier C, Scherman D, Heymann D, Rédini F, Trichet V.

Cancer Gene Ther. 2010 Jun;17(6):387-97. doi: 10.1038/cgt.2009.89. Epub 2010 Jan 15.

PMID:
20075983
16.

Hypoxia and hypoglycaemia in Ewing's sarcoma and osteosarcoma: regulation and phenotypic effects of Hypoxia-Inducible Factor.

Knowles HJ, Schaefer KL, Dirksen U, Athanasou NA.

BMC Cancer. 2010 Jul 16;10:372. doi: 10.1186/1471-2407-10-372.

17.

ErbB3 silencing reduces osteosarcoma cell proliferation and tumor growth in vivo.

Jullien N, Dieudonné FX, Habel N, Marty C, Modrowski D, Patino A, Lecanda F, Sévère N, Marie PJ.

Gene. 2013 May 25;521(1):55-61. doi: 10.1016/j.gene.2013.03.031. Epub 2013 Mar 27.

PMID:
23541807
18.

Vector-based Ape1 small interfering RNA enhances the sensitivity of human osteosarcoma cells to endostatin in vivo.

Wang D, Zhong ZY, Li MX, Xiang DB, Li ZP.

Cancer Sci. 2007 Dec;98(12):1993-2001. Epub 2007 Sep 24.

20.

High CD49f expression is associated with osteosarcoma tumor progression: a study using patient-derived primary cell cultures.

Penfornis P, Cai DZ, Harris MR, Walker R, Licini D, Fernandes JD, Orr G, Koganti T, Hicks C, Induru S, Meyer MS, Khokha R, Barr J, Pochampally RR.

Cancer Med. 2014 Aug;3(4):796-811. doi: 10.1002/cam4.249. Epub 2014 May 7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk